Strategy Asset Managers’s Biogen BIIB Stock Holding History

Strategy Asset Managers’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$885K	Buy	+3,920	New	+$831K	0.14%	115

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Strategy Asset Managers's BIIB Position: Q3 2026 in Review

Strategy Asset Managers opened a new position in Biogen (BIIB) in Q3 2026: 3,920 shares worth $885K. The stake represents 0.14% of the portfolio and ranks #115 among its holdings.

168 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Strategy Asset Managers held 3,920 shares of Biogen worth $885K as of Q3 2026.
Biogen was a new Strategy Asset Managers position in Q3 2026.
Biogen made up 0.14% of Strategy Asset Managers's portfolio in Q3 2026, its #115 holding.
168 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Strategy Asset Managers's 13F filing for Q3 2026, filed 14 Oct 2026.